Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis.

Sherin IsmailMichele Jonsson Funk Jennifer E Flythe

Published in: Journal of the American Society of Nephrology : JASN (2024)

Compared with initiation of antiemetics with lesser QT prolonging potential, initiation of ondansetron was associated with higher short-term cardiac risks among people receiving hemodialysis.

Keyphrases

end stage renal disease
peritoneal dialysis
chronic kidney disease
human health
chemotherapy induced
left ventricular
risk assessment
drug induced
heart failure
climate change